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Abstract
Lactate, indispensable substrate of mammalian intermediary
metabolism, allows shuttling of carbons and reducing power
between cells and organs at a high turnover rate. Lactate is,
therefore, not deleterious, although an increase in its concentration
is often a sensitive sign of alteration in energy homeostasis, a rise
in it being frequently related to poor prognosis. Such an increase,
however, actually signifies an attempt by the body to cope with a
new energy status. Hyperlactatemia, therefore, most often
represents an adaptive response to an acute energy disorder.
Investigation of lactate metabolism at the bedside is limited to the
determination of its concentration. Lactate metabolism and acid-
base homeostasis are both closely linked to cellular energy
metabolism, acidosis being potentially a cause or a consequence
of cellular energy deficit.
Lactate is certainly not a pyromaniac: it is not toxic and
possesses no harmful effect per se. It is probably a
trustworthy sentinel because it sensitively indicates that fire is
potentially in the house and numerous works have already
shown a good relationship between lactate level and
outcome [1]. Above all, it is an indispensable soldier that
actively acts as a major intermediate involved in the vast
cellular and organ energy interplay, allowing the body to cope
with a wide range of metabolic disorders (for example,
exercise, hypoxia, ischemia, severe sepsis, shock) [2].
Based on their broad experience in the management of the
profound metabolic derangements observed in critical
illnesses, associated with some experimental data, Valenza et
al. [3] propose, in a review-hypothesis paper in this issue of
Critical Care, to regard lactate increase in the intensive care
unit as a marker of a metabolic adaptation requiring a
therapeutic aid (“possibly indicating that ‘there is still room’ to
boost fast intervention”) rather than a sign of irreversible end-
stage energy failure. In this context, these authors propose to
take the decrease in blood lactate following a therapeutic
challenge as a major indicator of the efficacy of such
treatment. This proposal seems absolutely correct and very
close to what has been already proposed regarding oxygen
consumption (VO2), but with a simple bedside parameter of
metabolic integration. Indeed, whatever the cause of
derangement and the metabolic environment, any rise in
blood lactate indicates an attempt by the body to adapt to an
unusual energetic situation, which may affect redox state,
phosphate potential or pH [4]. Moreover, as indicated by the
authors, lactate production requires a complete glycolytic
pathway, that is, an intact cell with sufficient glucose supply
or glycogen storage. Therefore, in ischemic tissues, which
don’t have a sustained supply of blood glucose, a substantial
amount of lactate can be released as long as glucose is
present in the interstitial fluid or in the cells (glycogen). Thus,
it should be noted that a decrease in lactate might imply ‘a
correction’ of the initial disorder but also an exhaustion of the
precursor (glucose) or a destruction of tissues.
In fact, as for any metabolite, lactate concentration depends
on the ratio between production and consumption. Because
these two parameters are not routinely assessed at the
bedside, however, the pathophysiological view is mostly
based on lactate concentration only, which may represent a
sometimes hazardous shortcut. Lactate metabolism is
intimately linked to the three major potentials of living
systems, all strictly related to energy metabolism: redox
potential ((NADH, H+)/NAD+); phosphate potential (ATP/
(ADP × Pi)); and hydrogen potential or pH (6.1 + log(HCO3-/
0.03 × PaCO2)). The first indicates a potential deficit in
oxidation (oxygen or oxidative capacity), the second
shortage in energy and the third, which is closely linked to
these parameters, could be viewed as a metabolic tool
allowing the exact matching between them. ATP turnover is
controlled by pH [5-10]: acidosis decreases ATP turnover
and oxygen demand, representing an adapted or
deleterious event depending on how deep, how long and
how reversible.
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Although there is no doubt about the fact that a change in
lactate metabolism is linked to energy imbalance, the complete
picture of the mechanisms involved in lactate regulation, which
represents just a piece of a very complex puzzle, triggering or
inducing an adaptive response is not completely clear as yet.
However, anaerobic ATP supply from a glycolytic anaerobic
source is limited in terms of its sustained rate of ATP
production, except for a very acute and short muscle
contraction. As a matter of fact, 300 ml/minute oxygen
consumption (VO2 = 13.4 mmol O2) represents an ATP
turnover of approximately 80 mmol/minute, which costs about
1.6 mmol/minute (0.3 g) of glucose when oxidized and
40 mmol/minute (7.2 g) when metabolized anaerobically.
Hence, the entirety of liver glycogen would be consumed in
about 15 minutes as there is no glucose release from glycogen
in muscle cells because of the lack of glucose-6 phosphatase.
With the exception of initial muscle contraction, increased
anaerobic glycolytic ATP production is adaptive for a fall in
mitochondrial (aerobic) ATP supply only when associated with
a decrease in ATP consumption, imposing a new hierarchical
setting on the different ATP consuming pathways. In other
words, lactate-associated (anaerobic) ATP production is an
appropriate response to ischemia, anoxia or any kind of energy
crisis only when the body can simultaneously save energy. The
consequences of these changes in cell priorities represent a
major aspect of understanding metabolic derangement in acute
organ failure. Acidosis is linked to energy metabolism and
lactate homeostasis is related to both pH and energy status.
When metabolic or respiratory acidosis is the initial event, it
depresses energy expenditure and lactate might rise, but only
modestly. Correction of acidosis improves the energetic
derangement. In contrast, when the primary defect concerns
energy homeostasis, pH decrease is adaptive: lowering energy
expenditure allows matching a decrease in oxidative ATP
synthesis capacity and the rise in lactate concentration and
turnover is part of this adaptation. It should also be considered
that rises in lactate also occur frequently in the absence of
acidosis, or even simultaneously with alkalosis. Indeed, several
causes of hyperlactatemia encountered in intensive care unit
patients appear to be independent of any defect in cellular
energy status [11,12]. In these situations, the significance and
prognostic value of such hyperlactatemia are very different from
those associated with acidosis.
In conclusion, the significance of hyperlactatemia depends on
the concomitant acid-base status because of a common link
with energy metabolism. When acidosis is the primary cause
of the metabolic abnormalities, cellular energy deficit is a
consequence, lactate rise is modest and correction of pH
improves the metabolic disorder. When the cellular energy
defect is the primum movens, hyperlactatemia and acidosis
are its consequences and pH correction without simultaneous
improvement of the energy defect impairs the adaptive
response to energy failure, as represented by acidosis. When
lactate increases in the absence of acidosis, it probably
indicates a lack of a relationship with energy deficit.
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